Metastatic bladder cancer Inovio Pharmaceuticals

Inovio doses first patient in Phase l/lla of INO-5401 and atezolizumab

Inovio Pharmaceuticals has dosed its first patient in a Phase l/lla trial to analyse the safety, immunogenicity and clinical efficacy…